Plasma is a key ingredient in ECI’s novel formulation.
human plasma
Plasma is a key ingredient in ECI’s novel formulation.
ECI’s developing novel products with the goal of combining the tissue-repairing benefits of plasma or plasma derivatives with the sustained action of chitosan, to provide both relief and long-lasting therapeutic action.
Plasma is rich in growth factors and proteins. These components are known to promote cell proliferation, tissue regeneration, and repair, making them beneficial for healing, and naturally hydrating dry mucosal membranes.
for eyes
The healing properties of plasma may be ideal for addressing the damaged ocular surface often associated with Dry Eye Disease (DED). Moreover, plasma offers a semblance to the properties of natural tears. This means that patients can experience alleviation from the uncomfortable, gritty sensations typical of DED. Another advantage of plasma is its potential anti-inflammatory effects, which directly tackle one of the root causes of DED.
for wound care
Plasma, especially when it comes in the form of platelet-rich plasma (PRP), is teeming with growth factors, proteins, and other bioactive molecules, all of which are advantageous for the health of surface cells. These growth factors present in plasma have the ability to stimulate cell growth and significantly enhance the healing of wounds.
for mucosal membranes
Plasma’s growth factors and proteins promote cell proliferation, tissue regeneration, and repair, potentially making them beneficial for mucosal health. Additionally, the inherent composition of plasma naturally hydrates dry mucosal membranes.
human plasma and safety
Plasma is collected at an FDA licensed blood center through a typical blood donation process.
Blood centers perform multiple safety tests before releasing any blood product for further processing or use. In addition, a licensed pathogen-inactivation (pathogen reduction) process and specialized filtration enhances the safety and quality of our products.
learn more about:
our products
Our therapeutic formulation is suitable for a variety of products, including liquid eye drops, gels, ointments, contact lenses, contoured bandages, and wound dressings. We believe this formulation will promote healing of epithelial (surface cell) disorders, such as dry eye disease, ophthalmic burns, and chronic wounds.
patients
Patients who experience conditions ranging from dry eye disease, to diabetic ulcers, and wounds or burns may benefit from our fusion of plasma and chitosan as a forward-thinking and potent strategy to potentially address their conditions with easier access and fewer side effects.
our platform
Our platform leverages plasma from donated human blood and a proprietary antimicrobial molecule (form of chitosan). The tissue-repairing benefits of plasma-derived products, combined with the sustained action of chitosan, may provide relief and long-lasting therapeutic action.